Summary
Background: Gastro-oesophageal reflux disease has a complex pathophysiology. Therefore, therapeutic considerations should not only include the peptic component of the disease.
Methods: A variety of studies in rats and in humans demonstrate the consequences of gastro-oesophageal reflux and medical and surgical interventions in terms of inflammation, epithelial growth stimulation, apoptosis and oxidative stress in the epithelium of the oesophagus.
Results: Gastro-oesophageal reflux disease consists of a variety of pathophysiologically important factors. These include changes in the anatomy, gastro-oesophageal motility, epithelial growth, inflammation, apoptosis and molecular structure and may lead to carcinogenesis. Surgery restores the antireflux barrier and improves oesophageal and gastric motility, thus preventing the consequences of the disease.
Conclusions: Antireflux surgery provides a causative therapy of gastrointestinal reflux disease.
Zusammenfassung
Grundlagen: Die gastroösophageale Refluxkrankheit hat einen breiten pathophysiologischen Hintergrund und läßt sich somit auch in bezug auf die Therapie nicht auf die peptische Komponente reduzieren.
Methodik: In mehreren Untersuchungen sowohl an der Ratte als auch am Menschen werden die Auswirkungen des gastroösophagealen Refluxes und die Effekte medikamentöser und chirurgischer Maßnahmen in Hinblick auf Entzündung, Wachstumsstimulation, Apoptose und Auftreten von freien Sauerstoffradikalen am Ösophagusepithel demonstriert.
Ergebnisse: Die gastroösophageale Refluxkrankheit umspannt eine breite Palette von Veränderungen in bezug auf Anatomie, Motilität, Entzündung mit Freisetzung von Sauerstoffradikalen, Apoptose und DNA-Struktur bis hin zur Karzinogenese im distalen Ösophagus. Die chirurgische Therapie der Refluxkrankheit vermag eine ausreichende Barriere am Hiatus wiederherzustellen, verbessert die Magenmotilität und die Ösophagusperistaltik und ist in der Lage, dem gastroösophagealen Reflux mit all seinen Auswirkungen entgegenzuwirken.
Schlußfolgerungen: Die Antirefluxchirurgie stellt somit eine kausale Therapie der Refluxkrankheit dar.
Similar content being viewed by others
References
Attwood SE: Barrett’s esophagus. Curr Opin Gen Surg 1993:180–188.
Attwood SE, Smyrk TC, DeMeester TR, Mirvish SS, Stein HJ, Hinder RA: Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 1992;111:503–510.
Bagchi D, Das DK, Engelman RM, Prasad MR, Subramanian R: Polymorphonuclear leucocytes as potential source of free radicals in the ischaemic-reperfused myocardium. Eur Heart J 1990;11:800–813.
Bagchi M, Hassoun EA, Bagchi D, Stohs SJ. Endrin-induced increases in hepatic lipid peroxidation, membrane microviscosity, and DNA damage in rats. Arch Environ Contam Toxicol 1992;23:1–5.
Bagchi M, Hassoun EA, Bagchi D, Stohs SJ: Production of reactive oxygen species by peritoneal macrophages and hepatic mitochondria and microsomes from endrin-treated rats. Free Radic Biol Med 1993;14:149–155.
Bagchi M, Stohs SJ: In vitro induction of reactive oxygen species by 2,3,7,8-tetrachlorodibenzo-p-dioxin, endrin, and lindane in rat peritoneal macrophages, and hepatic mitochondria and microsomes. Free Radic Biol Med 1993;14:11–18.
Bankson DD, Kestin M, Rifai N: Role of free radicals in cancer and atherosclerosis. Clin Lab Med 1993;13:463–480.
Bass BL, Trad KS, Harmon JW, Hakki FZ: Capsaicin-sensitive nerves mediate esophageal mucosal protection. Surgery 1991;110:419–425 (discussion 425–426).
Bonavina L, Evander A, DeMeester TR, Walther B, Cheng SC, Palazzo L, Concannon JL: Length of the distal esophageal sphincter and competency of the cardia. Am J Surg 1986;151:25–34.
Bremner RM, Crookes PF, DeMeester TR, Peters JH, Stein HJ: Concentration of refluxed acid and esophageal mucosal injury. Am J Surg 1992;164:522–526 (discussion 526–527).
Brown CM, Rees WD: Review article: factors protecting the oesophagus against acid-mediated injury. Aliment Pharmacol Ther 1995;9:251–262.
Buege J, Aust S: Microsomal lipid peroxidation. Methods Enzymol 1972;52:302–310.
Caldwell MT, Byrne PJ, Brazil N, Crowley V, Attwood SE, Walsh TN, Hennessy TP: An ambulatory bile reflux monitoring system: an in vitro appraisal. Physiol Meas 1994;15:57–65.
Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, Hinder RA, Bremner CG, DeMeester TR: Is Barrett’s metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609–614.
Del Soldato P, Foschi D, Beboni G, Scarpignato C: Oxygen derived free radicals interact with indomethacin to cause gastrointestinal injury. Agents Actions 1985;17:484–488.
DeMeester SR, DeMeester TR: Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000;231:303–321.
DeMeester TR, Wang CI, Wernly JA, Pellegrini CA, Little AG, Klementschitsch P, Bermudez G, Johnson LF, Skinner DB: Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg 1980;79:656–670.
DeVault KR: Overview of therapy for the extraesophageal manifestations of gastroesophageal reflux disease. Am J Gastroenterol 2000;95(8 Suppl):S39-S44.
Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I: Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046–1052.
Dodds WJ, Hogan WJ, Helm JF, Dent J: Pathogenesis of reflux esophagitis. Gastroenterology 1981;81:376–394.
Eckardt VF: Does healing of esophagitis improve esophageal motor function? Dig Dis Sci 1988;33:161–165.
Eckardt VF, Kanzler G, Bernhard G: Life expectancy and cancer risk in patients with Barrett’s esophagus: a prospective controlled investigation. Am J Med 2001;111:33–37.
Fibbę C, Layer P, Keller J, Strate U, Emmermann A, Zornig C: Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology 2001;121:5–14.
Fiorucci S, Santucci L, Chiucchiu S, Morelli A: Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis [see comments]. Gastroenterology 1992;103:855–861.
Gadenstatter M, Klingler A, Klocker H, Wetscher GJ: Long-term results of laparoscopic partial posterior fundoplication in patients with esophageal reflux and disorders of esophageal peristalsis. Wien Klin Wochenschr 2000;112:70–74.
Gadenstatter M, Klingler A, Prommegger R, Hinder RA, Wetscher GJ: Laparoscopic partial posterior fundoplication provides excellent intermediate results in GERD patients with impaired esophageal peristalsis. Surgery 1999;126:548–552.
Gadenstatter M, Prommegger R, Klingler A, Schwelberger H, Weiss HG, Glaser K, Wetscher GJ: Alterations of gut neuropeptides in gastroesophageal reflux disease are resolved after antireflux surgery. Am J Surg 2000;180:483–487.
Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493–501.
Gillen P, Keeling P, Byrne PJ, Hennessy TP: Barrett’s oesophagus: pH profile. Br J Surg 1987;74:774–776.
Granderath FA, Kamolz T, Schweiger UM, Bammer T, Pointner R: Quality of life and subjective evaluation of outcome quality 3 years after laparoscopic antireflux surgery. Chirurg 2000;71:950–954.
Green D, Martin S: The killer and the executioner: how apoptosis controls malignancy. Curr Opin Immunol 1995;7:694–703.
Haegele AD, Briggs SP, Thompson HJ: Antioxidant status and dietary lipid unsaturation modulate oxidative DNA damage. Free Radic Biol Med 1994;16:111–115.
Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC: Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 1984;310:284–288.
Heyman S, Kirkpatrick JA, Winter HS, Treves S: An improved radionuclide method for the diagnosis of gastroesophageal reflux and aspiration in children (milk scan). Radiology 1979;131:479–482.
Hinder RA, Stein HJ: Oxygen-derived free radicals. Arch Surg 1991;126:104–105.
Iascone C, DeMeester TR, Little AG, Skinner DB: Barrett’s esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg 1983;118:543–549.
Kamolz T, Bammer T, Pasiut M, Pointner R: Health-related and disease-specific quality of life assessment after laparoscopic repeated fundoplication. Chirurg 2000;71:707–711.
Kamolz T, Bammer T, Wykypiel H Jr, Pasiut M, Pointner R: Quality of life and surgical outcome after laparoscopic Nissen and Toupet fundoplication: one-year follow-up. Endoscopy 2000;32:363–368.
Kamolz T, Wykypiel H Jr, Bammer T, Pointner R: Quality of life after laparoscopic antireflux surgery — Nissen fundoplication. Chirurg 1998;69:947–950.
Katada N, Hinder RA, Smyrk TC, Hirabayashi N, Perdikis G, Lund RJ, Woodward T, Klingler PJ: Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus. Arch Surg 1997;132:728–733.
Kramer EL, Sanger JJ: Esophageal reflux demonstrated on a hepatobiliary scan. Clin Nucl Med 1984;9:161–162.
Krausz Y, Maayan C, Faber J, Marciano R, Mogle P, Wynchank S: Scintigraphic evaluation of esophageal transit and gastric emptying in familial dysautonomia. Eur J Radiol 1994;18:52–56.
Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH: Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett’s oesophagus. J Pathol 1995;175:175–180.
Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WC, Teijgeman R, Mulder AH, Bosman FT, van Dekken H: Accumulation of genetic abnormalities during neoplastic progression in Barrett’s esophagus. Cancer Res 1995;55:1971–1976.
Langhans P, Heger RA, Hohenstein J, Schlake W, Bunte H: Operation-sequel carcinoma of the stomach. Experimental studies of surgical techniques with or without resection. World J Surg 1981;5:595–605.
Lepoivre M, Flaman JM, Henry Y: Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. J Biol Chem 1992;267:22994–3000.
Marcinkiewicz M, Han K, Zbroch T: The potential role of the esophageal pre-epithelial barrier components in the maintenance of integrity of the esophageal mucosa in patients with endoscopically negative gastroesophageal reflux disease. Am J Gastroenterol 2000;95:1652–1660.
Marshall RE, Anggiansah A, Owen WJ: Bile in the oesophagus: clinical relevance and ambulatory detection. Br J Surg 1997;84:21–28.
Mason R, Filipe I: The aetiology of gastric stump carcinoma in the rat. Scand J Gastroenterol 1990;25:961–965.
Muldoon DF, Hassoun EA, Stohs SJ: Ricin-induced hepatic lipid peroxidation, glutathione depletion, and DNA single-strand breaks in mice. Toxicon 1992;30:977–984.
O’Connor JB, Falk GW, Richter JE: The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus: report on the Cleveland Clinic Barrett’s Esophagus Registry. Am J Gastroenterol 1999;94:2037–2042.
Orlando RC, Bozymski EM: Heartburn in pernicious anemia — a consequence of bile reflux. N Engl J Med 1973;289:522–523.
Perdikis G, Wilson P, Hinder R, Redmond E, Wetscher G, Neary P, Adrian T, Quigley E: Altered antroduodenal motility after cholecystectomy. Am J Surg 1994;168:609–614 (discussion 614–615).
Perdikis G, Wilson P, Hinder RA, Redmond EJ, Wetscher GJ, Sacki S, Adrian TE: Gastroesophageal reflux disease is associated with enteric hormone abnormalities. Am J Surg 1994;167:186–191 (discussion 191–192).
Pihan G, Regillo C, Szabo S: Free radicals and lipid peroxidation in ethanol-or aspirin-induced gastric mucosal injury. Dig Dis Sci 1987;32:1395–1401.
Pointner R, Wetscher GJ, Gadenstatter M, Bodner E, Hinder RA: Gastric remnant cancer has a better prognosis than primary gastric cancer. Arch Surg 1994;129:615–619.
Sarosick J, McCallum RW: Do salivary organic components play a protective role in health and disease of the esophageal mucosa? Digestion 1995;56(Suppl 1):32–37.
Sarosiek J, McCallum RW: What is the secretory potential of submucosal mucous glands within the human gullet in health and disease? Digestion 1995;56(Suppl 1):15–23.
Savary M, Miller G: The Esophagus. Handbook and Atlas of Endoscopy. Solothurn, Switzerland, Gassmann AG, 1978.
Schwizer W, Hinder RA, DeMeester TR: Does delayed gastric emptying contribute to gastroesophageal reflux disease? Am J Surg 1989;157:74–81.
Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS: Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology 2000;119:333–338.
Singh S, Bradley LA, Richter JE: Determinants of oesophageal ‘alkaline’ pH environment in controls and patients with gastro-oesophageal reflux disease. Gut 1993;34:309–316.
Smyrk T: Histology in the diagnosis of foregut disease. In: Hinder R, Nyhus L (eds): Problems in General Surgery. Philadelphia, Lippincott Company, 1992, pp 14–38.
Sonnenberg A, Muller-Lissner SA, Weiser HF, Muller-Duysing W, Heinzel F, Blum AL: Effect of liquid meals on duodenogastric reflux in humans. Am J Physiol 1982;243:G42-G47.
Stein H, Hoeft S, De Meester T: Reflux and motility pattern in Barrett’s esophagus. Dis Esoph 1992;5:21–28.
Stein HJ, Barlow AP, DeMeester TR, Hinder RA: Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 1992;216:35–43.
Stein HJ, Esplugues J, Whittle BJ, Bauerfeind P, Hinder RA, Blum AL: Direct cytotoxic effect of oxygen radicals on the gastric mucosa. Surgery 1989;106:318–323 (discussion 323–324).
Stein HJ, Eypasch EP, DeMeester TR, Smyrk TC, Attwood SE: Circadian esophageal motor function in patients with gastroesophageal reflux disease. Surgery 1990;108:769–777 (discussion 777–778).
Stein HJ, Feussner H, Kauer W, DeMeester TR, Siewert JR: Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg 1994;167:163–168.
Stein HJ, Hinder RA, Oosthuizen MM: Gastric mucosal injury caused by hemorrhagic shock and reperfusion: protective role of the antioxidant glutathione. Surgery 1990;108:467–473 (discussion 473–474).
Stelzner F, Lierse W: The angiomuscular dilation closing of the terminal esophagus. Langenbecks Arch Chir 1968;321:35–64.
Taylor PR, Mason RC, Filipe MI, Vaja S, Hanley DC, Murphy GM, Dowling RH, McColl I: Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labelling index. Gut 1991;32:1447–1454.
Vaezi MF, Singh S, Richter JE: Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995;108:1897–1907.
von Ritter C, Hinder RA, Oosthuizen MM, Svensson LG, Hunter SJ, Lambrecht H: Gastric mucosal lesions induced by hemorrhagic shock in baboons. Role of oxygen-derived free radicals. Dig Dis Sci 1988;33:857–864.
Wetscher G, Gadenstätter M: Pathophysiology of Gastroesophageal Reflux Disease. Acta Chir Austriaca 1999;31:346–349.
Wetscher G, Redmond E, Vitito L: Pathophysiology of gastroesophageal reflux disease. In: Hinder R (ed.): Gastroesophageal reflux disease. Austin, Texas, Medical Intelligence Unit, R.G. Landes Company, 1993, pp 7–29.
Wetscher GJ, Bagchi M, Bagchi D, Perdikis G, Hinder PR, Glaser K, Hinder RA: Free radical production in nicotine treated pancreatic tissue. Free Radic Biol Med 1995;18:877–882.
Wetscher GJ, Gadenstaetter M, Klingler PJ, Weiss H, Obrist P, Wykypiel H, Klaus A, Profanter C: Efficacy of Medical Therapy and Antireflux Surgery to Prevent Barrett’s Metaplasia in Patients With Gastroesophageal Reflux Disease. Ann Surg 2001;234:627–632.
Wetscher GJ, Glaser K, Gadenstaetter M, Profanter C, Hinder RA: The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture. Am J Surg 1999;177:189–192.
Wetscher GJ, Glaser K, Wieschemeyer T, Gadenstaetter M, Prommegger R, Profanter C: Tailored antireflux surgery for gastroesophageal reflux disease: effectiveness and risk of postoperative dysphagia. World J Surg 1997;21:605–610.
Wetscher GJ, Hinder PR, Bagchi D, Perdikis G, Redmond EJ, Glaser K, Adrian TE, Hinder RA: Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci 1995;40:1292–1296.
Wetscher GJ, Hinder RA, Bagchi D, Hinder PR, Bagchi M, Perdikis G, McGinn T: Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 1995;170:552–556 (discussion 556–557).
Wetscher GJ, Hinder RA, Kretchmar D, Stinson R, Perdikis G, Smyrk T, Klingler PJ, Adrian TE: Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade. Dig Dis Sci 1996;41:2166–2173.
Wetscher GJ, Hinder RA, Perdikis G, Wieschemeier T, Stalzer R: Three-dimensional imaging of the lower esophageal sphincter in healthy subjects and gastroesophageal reflux. Dig Dis Sci 1996;41:2377–2382.
Wetscher GJ, Hinder RA, Smyrk T, Perdikis G, Adrian TE, Profanter C: Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. Dig Dis Sci 1999;44:1132–1135.
Wetscher GJ, Perdikis G, Kretchmar DH, Stinson RG, Bagchi D, Redmond EJ, Adrian TE, Hinder RA: Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci 1995;40:1297–1305.
Wetscher GJ, Profanter C, Gadenstatter M, Perdikis G, Glaser K, Hinder RA: Medical treatment of gastroesophageal reflux disease does not prevent the development of Barrett’s metaplasia and poor esophageal body motility. Langenbecks Arch Chir 1997;382:95–99.
Wetscher GJ, Schwelberger H, Unger A, Offner FA, Profanter C, Glaser K, Klingler A, Gadenstaetter M, Klinger P: Reflux-induced apoptosis of the esophageal mucosa is inhibited in Barrett’s epithelium. Am J Surg 1998;176:569–573.
Zaninotto G, Di Mario F, Costantini M, Baffa R, Germana B, Dal Santo PL, Rugge M, Bolzan M, Naccarato R, Ancona E: Oesophagitis and pH of refluxate: an experimental and clinical study. Br J Surg 1992;79:161–164.
Zhang F, Altorki NK, Wu YC, Soslow RA, Subbaramaiah K, Dannenberg AJ: Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001;121:1391–1399.
Zhang F, Subbaramaiah K, Altorki N, Dannenberg AJ: Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J Biol Chem 1998;273:2424–2428.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wykypiel, H., Gadenstätter, M., Granderath, F.A. et al. Pathophysiology of gastro-oesophageal reflux disease (GERD) with respect to reflux-induced carcinogenesis. Eur. Surg. 34, 296–302 (2002). https://doi.org/10.1046/j.1563-2563.2002.02071.x
Published:
Issue Date:
DOI: https://doi.org/10.1046/j.1563-2563.2002.02071.x